{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:51:59Z","timestamp":1788994319050,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T00:00:00Z","timestamp":1681776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T00:00:00Z","timestamp":1681776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-023-09577-1","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T13:03:41Z","timestamp":1681823021000},"page":"6569-6581","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Efficacy and safety of N-acetylcysteine for preventing post-intravenous contrast acute kidney injury in patients with kidney impairment: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"33","author":[{"given":"Claudia","family":"Maestro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2272-7086","authenticated-orcid":false,"given":"Leire","family":"Leache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Guti\u00e9rrez-Valencia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Carlos","family":"Saiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carmen","family":"Bacaicoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Erviti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,18]]},"reference":[{"key":"9577_CR1","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1007\/s00330-017-5246-5","volume":"28","author":"AJ van der Molen","year":"2018","unstructured":"van der Molen AJ, Reimer P, Dekkers IA et al (2018) Post-contrast acute kidney injury \u2013 Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors. Eur Radiol 28:2845\u20132855","journal-title":"Eur Radiol"},{"key":"9577_CR2","doi-asserted-by":"crossref","unstructured":"Carbonell N, Sanju\u00e1n R, Blasco M,\u00a0Jord\u00e1 A,\u00a0Miguel A (2010) N-acetylcysteine: short-term clinical benefits after coronary angiography in high-risk renal patients.\u00a0Rev Esp Cardiol\u00a063:12\u201319","DOI":"10.1016\/S1885-5857(10)70004-9"},{"key":"9577_CR3","doi-asserted-by":"crossref","unstructured":"Tepel M, van der Giet M, Schwarzfeld C,\u00a0Laufer U,\u00a0Liermann D,\u00a0Zidek W (2000) Prevention of radiographic-contrast-agent\u2013induced reductions in renal function by acetylcysteine. N Engl J Med 343:180\u2013184","DOI":"10.1056\/NEJM200007203430304"},{"key":"9577_CR4","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1056\/NEJMra1805256","volume":"380","author":"R Mehran","year":"2019","unstructured":"Mehran R, Dangas GD, Weisbord SD (2019) Contrast-associated acute kidney injury. N Engl J Med 380:2146\u20132155","journal-title":"N Engl J Med"},{"key":"9577_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.nefrol.2017.03.001","volume":"14","author":"J Luis","year":"2017","unstructured":"Luis J, Morales F (2017) Actualidad en nefropat\u00eda por medio de contraste. Nefrolog\u00eda Latinoamericana Actualidad en nefropat\u00eda por medio de contraste. Nefrol Latinoam 14:69\u201378","journal-title":"Nefrol Latinoam"},{"key":"9577_CR6","doi-asserted-by":"crossref","unstructured":"Ferrario F, Barone MT, Landoni G et al (2009) Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy - a randomised controlled study. Nephrol Dial Transplant 24:3103\u20133107","DOI":"10.1093\/ndt\/gfp306"},{"key":"9577_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2020-039009","volume":"10","author":"Z Guo","year":"2020","unstructured":"Guo Z, Liu J, Lei L et al (2020) Effect of N-acetylcysteine on prevention of contrast-associated acute kidney injury in patients with STEMI undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomised controlled trials. BMJ Open 10:1\u20137","journal-title":"BMJ Open"},{"key":"9577_CR8","doi-asserted-by":"crossref","unstructured":"Wang N, Qian P, Kumar S,\u00a0Yan TD,\u00a0Phan K (2016) The effect of N-acetylcysteine on the incidence of contrast-induced kidney injury: a systematic review and trial sequential analysis. Int J Cardiol 209:319\u2013327","DOI":"10.1016\/j.ijcard.2016.02.083"},{"key":"9577_CR9","doi-asserted-by":"crossref","unstructured":"Sharp AJ, Patel N, Reeves BC,\u00a0Angelini GD,\u00a0Fiorentino F (2019) Pharmacological interventions for the prevention of contrast-induced acute kidney injury in high-risk adult patients undergoing coronary angiography: A systematic review and meta-analysis of randomised controlled trials. Open Hear 6:1\u201311","DOI":"10.1136\/openhrt-2018-000864"},{"key":"9577_CR10","doi-asserted-by":"crossref","unstructured":"Khan SU, Khan MU, Rahman H et al (2019) A Bayesian network meta-analysis of preventive strategies for contrast-induced nephropathy after cardiac catheterization. Cardiovasc Revasc Med 20:29\u201337","DOI":"10.1016\/j.carrev.2018.06.005"},{"key":"9577_CR11","doi-asserted-by":"crossref","unstructured":"Xie W, Liang X, Lin Z,\u00a0Liu M,\u00a0\u00a0Ling Z (2021) Latest clinical evidence about effect of acetylcysteine on preventing contrast-induced nephropathy in patients undergoing angiography: a meta-analysis. Angiology 72:105\u2013121","DOI":"10.1177\/0003319720950162"},{"key":"9577_CR12","doi-asserted-by":"crossref","unstructured":"O\u2019Sullivan S, Healy DA, Moloney MC,\u00a0Grace PA,\u00a0Walsh SR (2013) The role of N-acetylcysteine in the prevention of contrast-induced nephropathy in patients undergoing peripheral angiography: a structured review and meta-analysis. Angiology 64:576\u2013582","DOI":"10.1177\/0003319712467223"},{"key":"9577_CR13","doi-asserted-by":"crossref","unstructured":"Ali-Hassan-Sayegh S, Mirhosseini SJ, Ghodratipour Z et al (2017) Strategies preventing contrast-induced nephropathy after coronary angiography: a comprehensive metaanalysis and systematic review of 125 randomised controlled trials. Angiology 68:389\u2013413","DOI":"10.1177\/0003319716661445"},{"key":"9577_CR14","doi-asserted-by":"publisher","first-page":"687","DOI":"10.2214\/AJR.07.2356","volume":"189","author":"PA Poletti","year":"2007","unstructured":"Poletti PA, Saudan P, Platon A et al (2007) I.v. N-acetylcysteine and emergency CT: use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicity. AJR Am J Roentgenol 189:687\u2013692","journal-title":"AJR Am J Roentgenol"},{"key":"9577_CR15","doi-asserted-by":"crossref","unstructured":"Poletti PA, Platon A, De Seigneux S et al (2013) N-acetylcysteine does not prevent contrast nephropathy in patients with renal impairment undergoing emergency CT: a randomised study. BMC Nephrol 14:119","DOI":"10.1186\/1471-2369-14-119"},{"key":"9577_CR16","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2217\/14750708.3.6.773","volume":"6","author":"H Khalili","year":"2006","unstructured":"Khalili H, Dashti-Khavidaki S, Tabifar H et al (2006) N -acetylcysteine in the prevention of contrast agent-induced nephrotoxicity in patients undergoing computed tomography studies. Therapy 6:773\u2013777","journal-title":"Therapy"},{"key":"9577_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700","journal-title":"BMJ"},{"key":"9577_CR18","unstructured":"Higgins J, Thomas J, Chandler J (Senior Editors) Cochrane handbook for systematic reviews of interventions. Version 6.3. Cochrane, 2022. https:\/\/training.cochrane.org\/handbook\/current. Accessed 9 May 2022"},{"key":"9577_CR19","doi-asserted-by":"publisher","unstructured":"Leache L, Guti\u00e9rrez M, Maestro C, Saiz LC, Erviti J (2022) Efficacy and safety of N-acetylcysteine for preventing post-intravenous contrast acute kidney injury in patients with kidney impairment: protocol for a systematic review and meta-analysis. OSF. https:\/\/doi.org\/10.17605\/OSF.IO\/DHR27","DOI":"10.17605\/OSF.IO\/DHR27"},{"key":"9577_CR20","doi-asserted-by":"publisher","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) (2013) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3. https:\/\/doi.org\/10.1038\/kisup.2012.73","DOI":"10.1038\/kisup.2012.73"},{"key":"9577_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/kisup.2012.1","volume":"2","author":"Kidney Disease: Improving Global Ou","year":"2012","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO), (2012) Acute kidney injury work group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl 2:1\u2013138","journal-title":"Kidney Int Suppl"},{"key":"9577_CR22","unstructured":"Review Manager (RevMan) [Computer program] (2020) Version 5.4. The cochrane collaboration. https:\/\/training.cochrane.org\/online-learning\/core-software\/revman\/revman-5-download. Accessed 9 May 2022"},{"key":"9577_CR23","unstructured":"Higgins JPT, Green S (Editors) Cochrane handbook for systematic reviews of interventions. Version 5.1.0. The Cochrane Collaboration, 2011. https:\/\/handbook-5-1.cochrane.org\/. Accessed 9 May 2022"},{"key":"9577_CR24","doi-asserted-by":"crossref","unstructured":"Guyatt GH, Oxman AD, Vist GE,: GWG, et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336:924\u2013926","DOI":"10.1136\/bmj.39489.470347.AD"},{"key":"9577_CR25","doi-asserted-by":"crossref","unstructured":"Burns KEA, Priestap F, Martin C (2010) N-acetylcysteine in critically ill patients undergoing contrast-enhanced computed tomography: a randomised trial. Clin Nephrol 74:323\u2013326","DOI":"10.5414\/CNP74323"},{"key":"9577_CR26","doi-asserted-by":"crossref","unstructured":"Kitzler TM, Jaberi A, Sendlhofer G et al (2012) Efficacy of vitamin E and N-acetylcysteine in the prevention of contrast induced kidney injury in patients with chronic kidney disease\u202f: a double blind, randomised controlled trial. Wien Klin Wochenschr 124:312\u2013319","DOI":"10.1007\/s00508-012-0169-2"},{"key":"9577_CR27","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.annemergmed.2013.04.012","volume":"62","author":"SJ Traub","year":"2013","unstructured":"Traub SJ, Mitchell AM, Jones AE et al (2013) N-Acetylcysteine plus intravenous fluids versus intravenous fluids alone to prevent contrast-induced nephropathy in emergency computed tomography. Ann Emerg Med 62:511-520.e25","journal-title":"Ann Emerg Med"},{"key":"9577_CR28","doi-asserted-by":"crossref","unstructured":"Huber W, Eckel F, Hennig M et al (2006) Prophylaxis of contrast material-induced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomised study. Radiology 239:793\u2013804","DOI":"10.1148\/radiol.2393041456"},{"key":"9577_CR29","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/nejmoa1710933","volume":"378","author":"SD Weisbord","year":"2018","unstructured":"Weisbord SD, Gallagher M, Jneid H et al (2018) Outcomes after angiography with sodium bicarbonate and acetylcysteine. N Engl J Med 378:603\u2013614. https:\/\/doi.org\/10.1056\/nejmoa1710933","journal-title":"N Engl J Med"},{"key":"9577_CR30","doi-asserted-by":"crossref","unstructured":"Kang X, Hu DY, Li CB,\u00a0Ai Z-S,\u00a0Peng A (2015) N-acetylcysteine for the prevention of contrast-induced nephropathy in patients with pre-existing renal insufficiency or diabetes: a systematic review and meta-analysis. Ren Fail 37:297\u2013303","DOI":"10.3109\/0886022X.2015.1012985"},{"key":"9577_CR31","doi-asserted-by":"crossref","unstructured":"Xu R, Tao A, Bai Y,\u00a0Deng Y,\u00a0Chen G (2016) Effectiveness of N-acetylcysteine for the prevention of contrast-induced nephropathy: a systematic review and meta-analysis of randomised controlled trials. J Am Hear Assoc 5:e003968","DOI":"10.1161\/JAHA.116.003968"},{"key":"9577_CR32","doi-asserted-by":"crossref","unstructured":"Magner K, Ilin JV, Clark EG,\u00a0Kong JWY,\u00a0Davis A,\u00a0Hiremath S (2022) Meta-analytic techniques to assess the association between N-acetylcysteine and acute kidney injury after contrast administration: a systematic review and meta-analysis. JAMA Netw Open 5:E2220671","DOI":"10.1001\/jamanetworkopen.2022.20671"},{"key":"9577_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2022.110368","volume":"153","author":"H Walker","year":"2022","unstructured":"Walker H, Guthrie GD, Lambourg E et al (2022) Systematic review and meta-analysis of prophylaxis use with intravenous contrast exposure to prevent contrast-induced nephropathy. Eur J Radiol 153:110368","journal-title":"Eur J Radiol"},{"key":"9577_CR34","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1007\/s00330-017-5247-4","volume":"28","author":"AJ van der Molen","year":"2018","unstructured":"van der Molen AJ, Reimer P, Dekkers IA et al (2018) Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients: Recommendations for updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol 28:2856\u20132869","journal-title":"Eur Radiol"},{"key":"9577_CR35","unstructured":"ACR Committee on Drugs and Contrast Media (2022) ACR manual on contrast media. https:\/\/www.acr.org\/Clinical-Resources\/Contrast-Manual.\u00a0Accessed 8 Feb 2023"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-09577-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-023-09577-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-09577-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T15:13:34Z","timestamp":1691680414000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-023-09577-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,18]]},"references-count":35,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["9577"],"URL":"https:\/\/doi.org\/10.1007\/s00330-023-09577-1","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,18]]},"assertion":[{"value":"14 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Leire Leache.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was not required because it is a systematic review conducted based on published data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was not required because it is a systematic review conducted based on published data.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"\u2022 systematic review\u2022 meta-analysis","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}